Kite Pharma, Inc.

Samuel T Haile

Amy E Gilbert

Matthew Drever

Kevin P Meng

Catherine A Hartzell

Edward H Liao

Jodi Murakami

Provided are chimeric antigen receptors (CARs) comprising an NGK2D ecto domain. Provided are compositions, cells and cell therapies comprising the same. Further provided are methods of treatment.

Chimeric antigen receptor

Provided are antibodies, fragments thereof, chimeric antigen receptors (CARs) and T cell receptors (TCRs) comprising one or more of the anti-PMCA antigen binding domains disclosed herein. SynNotch receptors that comprise an anti-PSCA binding domain Provided are polynucleotides encoding antibodies, fragments thereof, CARs, T cell receptors (TCR) and SynNotch receptors. Provided are compositions, cells and cell therapies comprising the same. Further provided are methods of treatment.

Prostate cancer chimeric antigen receptors

Growing community of inventors

Castro Valley, CA, United States of America

Samuel T Haile